Development of a portable A-ABR screener using a microprocessor

Hyung Wook Noh1, Tak Hyung Lee, Jong Wook Kim

  • 1Graduate Program in Biomedical Engineering, Yonsei University, Seoul, Korea. happy05@yuhs.ac

Insights

Early detection of infant hearing loss is crucial for speech development. A new automated auditory brainstem response (A-ABR) system offers a reliable method for identifying hearing impairment in newborns and infants.

Area of Science:

  • Audiology
  • Biomedical Engineering
  • Neonatal Care

Background:

  • Hearing loss is a common birth defect, often diagnosed late, hindering speech and language development.
  • Early intervention is critical for optimal speech and language outcomes in hearing-impaired children.
  • Auditory Brainstem Response (ABR) is a reliable diagnostic tool for early hearing loss detection.

Purpose of the Study:

  • To develop and validate a portable, automated Auditory Brainstem Response (A-ABR) system for early hearing impairment detection in infants.
  • To utilize the 'Fsp' method for distinguishing between normal and impaired hearing.
  • To assess the system's accuracy in identifying hearing status.

Main Methods:

  • Development of a battery-operated, portable automated auditory brainstem response (A-ABR) system.
  • Application of the 'Fsp' method for hearing impairment detection.
  • Partial validation of the A-ABR system's accuracy in a cohort of normal-hearing adults.

Main Results:

  • A functional A-ABR system was developed for automated hearing impairment detection.
  • The 'Fsp' method was employed to differentiate hearing statuses.
  • Initial validation demonstrated the system's potential, with further testing required.

Conclusions:

  • The developed A-ABR system shows promise for the early and automated detection of hearing impairment in neonates and infants.
  • Timely diagnosis through A-ABR can facilitate early intervention, improving speech and language development.
  • Further comprehensive validation studies are necessary to confirm the system's clinical efficacy.